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H5N1 highly pathogenic avian inﬂuenza virus (HPAIV) of clade 2.3.2 has been circulating in
waterfowl in Southern China since 2003. Our previous studies showed that certain H5N1
HPAIV isolates within clade 2.3.2 from Southern China had high pathogenicity in different
birds. Guinea pigs have been successfully used as models to evaluate the transmissibility
of AIVs and other species of inﬂuenza viruses in mammalian hosts. However, few studies
have reported pathogenicity and transmissibility of H5N1 HPAIVs of this clade in guinea
pigs. In this study, we selected an H5N1 HPAIV isolate, A/duck/Guangdong/357/2008, to
investigate the pathogenicity and transmissibility of the virus in guinea pigs. The virus
had high pathogenicity in mice; additionally, it only replicated in some tissues of the
guinea pigs without production of clinical signs, but was transmissible among guinea pigs.
Interestingly, virus isolates from co-caged guinea pigs had the D701N mutation in the PB2
protein. These mutant viruses showed higher pathogenicity in mice and higher replication
capability in guinea pigs but did not demonstrate enhanced the transmissibility among
guinea pigs.These ﬁndings indicate the transmission of the H5N1 virus between mammals
could induce virus mutations, and the mutant viruses might have higher pathogenicity
in mammals without higher transmissibility. Therefore, the continued evaluation of the
pathogenicity and transmissibility of avian inﬂuenza virus (AIVs) inmammals is critical to the
understanding of the evolutionary characteristics of AIVs and the emergence of potential
pandemic strains.
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INTRODUCTION
Avian inﬂuenza viruses (AIVs) are enveloped RNA viruses with
an eight-segmented, single-stranded, negative-sense genome, and
belong to the familyOrthomyxoviridae (Webster et al., 1992). They
are subtyped according to the characterization of hemagglutinin
(HA) andneuraminidase (NA) glycoproteins,which are located on
the outer surface of the virus envelope (Murti and Webster, 1986).
At present, sixteen HA and nine NA subtypes have been rec-
ognized; most have been found in aquatic birds, which are
the natural hosts of AIVs (Webster et al., 1992; Fouchier et al.,
2005; Alexander, 2007). To date, the literature reports that
only viruses of the H5 and H7 subtypes are highly pathogenic
(HP) in susceptible species (Hampson and Mackenzie, 2006;
Alexander, 2007).
H5N1 highly pathogenic avian inﬂuenza virus (HPAIV) iso-
lates derived from the goose/Guangdong/1/96 (Gs/GD) lineage
have been found in over sixty countries in Europe, Asia, and
Africa (Li et al., 2004). They not only cause high mortality in
birds and thus serious damage to the poultry industry; they also
occasionally infect humans and are feared to have be the poten-
tial source of a new pandemic ﬂu (Chen et al., 2004; Guan et al.,
2004; Li et al., 2004; Peiris et al., 2007; Wang et al., 2008). H5N1
viruses are grouped into ten clades (i.e., 0–9) and many subclades
based on the evolution of the HA gene. Viruses of clade 2.3.2
have been circulating widely in China since 2008 and could cause
a new wave of cross-continental spread of the disease from Asia
to Europe (Smith et al., 2009; Jiang et al., 2010; Li et al., 2010;
Sun et al., 2011).
The most commonly used mammalian model in the study
of the pathogenesis of AIVs and the evaluation of vaccines
and antiviral drugs is the mouse (Gubareva et al., 1998). One
clear advantage of a mouse model for AIVs infection is the
wide availability of reagents for immunologic studies with mice.
However, mice are not suitable for the study of the viral trans-
mission of AIVs because infected mice fail to transmit the
virus to other mice even when housed within the same cages
(Lowen et al., 2006).
Unlike mice, ferrets are suitable for both transmission and
pathogenesis studies, but the higher cost and large amount
of space required for housing this species severely limit the
number of animals that can be included in individual stud-
ies (Lowen and Palese, 2007). In an answer to this problem,
the guinea pig has recently emerged as an alternate model that
can be used to study the transmission of inﬂuenza viruses
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(Lowen et al., 2006). The guinea pig offers several advantages
as a mammalian animal model for studying inﬂuenza dis-
ease, including their high susceptibility to infection with human
inﬂuenza A viruses. In addition, their lungs contain bronchus-
associated lymphoid tissue similar to that of humans, and the
airway innervation of the guinea pig is very similar to that
of humans as well (Azoulay-Dupuis et al., 1984; Wang et al.,
2005). Guinea pigs have been successfully used as models to
evaluate the transmissibility of AIVs and other inﬂuenza viruses
in mammalian hosts (Lowen et al., 2006; Bouvier et al., 2008;
Lowen et al., 2009; Mubareka et al., 2009; Steel et al., 2009;
Van Hoeven et al., 2009).
Our previous studies demonstrated that a large number of
H5N1 HPAIVs within clade 2.3.2 from Southern China had high
pathogenicity in different birds (Sun et al., 2011; Yuan et al., 2014).
Some studies have investigated the pathogenicity and transmis-
sibility of H5N1 HPAIVs of this clade in mammals (Hu et al.,
2013; Xu et al., 2013). To better understand the pathogenicity of
these viruses in mice and guinea pigs and the transmissibility in
guinea pigs, we selected a clade 2.3.2 virus isolated in 2008 from
ducks to examine its lethality, replication and transmission in these
animals.
MATERIALS AND METHODS
VIRUS
The A/duck/Guangdong/357/2008 (DK357) virus used in this
studywas isolated fromducks in theGuangdongProvince of China
in 2008 and identiﬁed as H5N1 AIV by means of HA inhibition
and NA inhibition tests. The virus was puriﬁed and propa-
gated in the allantoic cavity of 10-day-old, speciﬁc-pathogen-free
(SPF), embryonated hens’ eggs. The allantoic ﬂuid from mul-
tiple eggs was pooled, clariﬁed by centrifugation, and frozen
in aliquots at −70◦C. The 50% egg infectious dose (EID50)
was calculated according to the method published by Reed and
Muench (1938) using the serial titration of eggs. All experi-
ments were carried out in Animal Biosafety Level 3 (ABSL-3)
facilities.
ANIMALS
Six-week-old female BALB/c mice and female Hartley strain
guinea pigs weighing 300–350 g were purchased from the Lab-
oratory Animal Center of South China in Guangzhou, China. The
mice and guinea pigs were conﬁrmed as serologically negative for
theAIVs used in these studies. The animals were housed inABSL-3
facilities.
MOUSE EXPERIMENTS
To determine morbidity and mortality, groups of eight 6-week-
old female BALB/c mice were lightly anesthetized with CO2
and inoculated intranasally with 106 EID50 of virus in a vol-
ume of 0.05 ml. Additionally, ﬁve mice were inoculated with
0.05 ml of phosphate buffered saline (PBS) and served as the
sham control group. Three mice in each group were eutha-
nized at 3 days post-inoculation (DPI), and the lungs, kidneys,
spleens, and brains were collected for virus titration in eggs
as described previously (Chen et al., 2004; Jiao et al., 2007).
The remaining mice were monitored daily for weight loss and
mortality to 14 DPI. Mice that lost more than 25% of their
original weight were euthanized for humane reasons. All ani-
mal experiments were conducted under the guidance of CDC’s
Institutional Animal Care and Use Committee and in an Asso-
ciation for Assessment and Accreditation of Laboratory Animal
Care International accredited facility. Our animal experiments
in this study had been approved by Guangdong Province Ani-
mal Disease Control Center and were carried out in ABSL-3
facilities.
GUINEA PIG EXPERIMENTS
In this study, intramuscular injections of ketamine (20 mg/kg)
and xylazine (1 mg/kg) were used to anesthetize guinea pigs.
To determine morbidity and mortality, groups of eight ani-
mals were anesthetized, and a 0.3 ml volume of inoculum
containing 106 EID50 of virus was instilled into the nostrils
(0.15 ml each side) of each guinea pig in the experimental groups.
Five guinea pigs were inoculated with 0.3 ml PBS and acted
as the sham control group. Three guinea pigs in each group
were euthanized at 3 DPI, and the nasal turbinates, tracheas,
lungs, brains, kidneys, spleens, livers, and colons were collected
for virus titration in eggs following the previously described
method (Chen et al., 2004). The remaining animals were mon-
itored daily for weight loss and mortality up to 14 DPI. All
animal experiments were conducted under the guidance of CDC’s
Institutional Animal Care and Use Committee and in an Asso-
ciation for Assessment and Accreditation of Laboratory Animal
Care International accredited facility. Our animal experiments
in this study had been approved by Guangdong Province Ani-
mal Disease Control Center and were carried out in ABSL-3
facilities.
CONTACT TRANSMISSION EXPERIMENTS BETWEEN GUINEA PIGS
To assess the transmissibility of the virus among guinea pigs,
three additional animals were inoculated intranasally with 106
EID50 of the test virus and housed in a cage. Five naive ani-
mals were introduced into the same cage 24 h later. Three
naive animals were euthanized at 5 days post contact (DPC),
and their organs were collected for virus titration in eggs fol-
lowing the previously described method (Chen et al., 2004).
The remaining animals were monitored daily for weight loss
and mortality up to 14 DPC. All animal experiments were
conducted under the guidance of CDC’s Institutional Animal
Care and Use Committee and in an Association for Assess-
ment and Accreditation of Laboratory Animal Care Inter-
national accredited facility. Our animal experiments in this
study had been approved by Guangdong Province Animal Dis-
ease Control Center and were carried out in ABSL-3 facili-
ties.
MOLECULAR CHANGE ANALYSIS
The viral RNA was extracted from the allantoic ﬂuid super-
natant using the RNeasy Mini Kit (Promega, Madison, WI,
USA), and the manufacturer’s instructions were followed. Reverse
transcription polymerase chain reaction (RT-PCR) was con-
ducted using the Superscript III (Invitrogen, Carlsbad, CA,
USA) and Uni12 (5′-AGCAAAAGCAGG-3′) primer. Eight genes
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were ampliﬁed using universal primers (Hoffmann et al., 2001),
and the PCR products were puriﬁed using the mini PCR
Puriﬁcation Kit (Promega). Sequencing was performed by
Shanghai Invitrogen Biotechnology Co., Ltd. The sequenc-
ing data were compiled with the Seqman program of Laser-
gene 7 (DNASTAR, Inc.). Amino acid sequence similarities
were identiﬁed with the Lasergene 7 Megalign program
(DNASTAR).
RESULTS
VIRUS PATHOGENICITY AND ORGAN TROPISM IN THE MOUSE MODEL
In the mouse experiment, clinical signs of illness were observed
in the experimental group as early as 3 DPI, and all mice exposed
to the virus were dead by 7 DPI (Figure 1). For the three mice
euthanized on 3 DPI, the mean virus titer was 5.8, 3.8, 3.3, and
3.9 log10EID50 in the lung, spleen, kidney, and brain, respectively
(Table 1). Infection with the DK/357 virus caused 23.1% loss of
body weight by 7 DPI, while the sham control group inoculated
with PBS increased in body weight by an average of 11.4% by
14 DPI. These ﬁndings illustrated that DK/357 virus had high
pathogenicity in mice.
VIRUS PATHOGENICITY AND ORGAN TROPISM IN THE GUINEA PIG
MODEL
In the mice studies, DK/357 was HP, i.e., causing 100% morbid-
ity and mortality. In contrast, in guinea pig model, infection
with the virus did not cause morbidity. What’s more, infec-
tion with the DK/357 virus only caused slight weight loss in
guinea pigs during the initial DPI. In the evaluation of the
organ tropism of the virus in the guinea pigs, the virus was
found in the nasal turbinates, tracheas, and lungs with mean
titers of 5.8, 2.6, and 5.6 log10EID50, respectively (Table 1). No
virus was isolated from any of the other collected guinea pig
tissues. These results indicated that DK/357 virus only replicated
in some tissues of the guinea pigs without production of clinical
signs.
TRANSMISSION OF THE VIRUS BETWEEN CO-CAGED GUINEA PIGS
In the investigation of virus transmission among co-caged guinea
pigs, the virus was isolated only from the nasal turbinates of
two guinea pigs with titers of 2.75 and 2 log10EID50, respec-
tively, at 5 DPC. At 9 DPC, one co-caged guinea pig showed
slight clinical symptoms. This guinea pig was euthanized,
and samples were collected for virus titration. The virus
was isolated from the trachea (named DK/357-T) and the
lung (named DK/357-L) with titers of 1.75 and 3 log10EID50,
respectively.
MOLECULAR CHANGE ANALYSIS BETWEEN ORIGINAL VIRUS ISOLATES
AND VIRUSES ISOLATED FROM THE TRACHEA AND LUNG OF THE
CO-CAGED GUINEA PIG
Viral RNAwas extracted from the trachea and lung of the co-caged
guinea pig, and RT-PCR was conducted. The PCR products
of eight genes from the viral RNA extracted from the trachea
and lung of the co-caged guinea pig were sequenced and were
compared to the sequence of the original virus isolate in order
to identify any molecular differences between the two. When
comparing DK/357 to the DK/357-T, three amino acids substi-
tutions were found, i.e., V96I and D701N in the polymerase PB2
protein and N417S in the nucleoprotein (NP) protein (Table 2).
In total, the following ﬁve amino acid changes between DK/357
and DK/357-L were identiﬁed: V96I, F135I, S688F, and D701N
in the polymerase PB2 protein and N417S in the NP protein
(Table 2).
PATHOGENICITY AND ORGAN TROPISM OF DK/357-T AND DK/357-L IN
THE MOUSE AND GUINEA PIG MODELS
All mice exposed to the DK/357-T and DK/357-L were dead
by 4 and 6 DPI, respectively (Figure 2). The DK/357-T
virus replicated systemically to the mean titers of 7, 3.9, 3.6,
and 4.3 log10EID50 in the lung, spleen, kidney, and brain,
respectively (Table 1). The virus titers in the detected tis-
sues were all higher than that of the original DK/357 virus.
FIGURE 1 | Lethality of the DK/357 virus to mice. Survival curves of the mice inoculated with DK/357 virus at a dose of 106 EID50.
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Table 1 | Replication of H5N1 avian influenza viruses in mice and guinea pigs.
Virus
strains
Virustiters in mice at 3 DPI (log10EID50/g) Virus titers in guinea pigs at 3 DPI (log10EID50/g)
Lung Spleen Kidney Brain Nasal
turbinate
Trachea Lung Brain Kidney Spleens Livers Colon
DK/357 5.8 ± 1.1a 3.8 ± 0.9 3.3 ± 0.8 3.9 ± 1.1 5.8 ± 1.5 2.6 ± 0.8 5.6 ± 1.4 –b – – – –
DK/357-T 7 ± 1.4 3.9 ± 1.1 3.6 ± 0.9 4.3 ± 0.9 6.8 ± 1.2 2.8 ± 0.8 6 ± 1.6 1.9 ± 0.7 – – – –
DK/357-L 6.6 ± 1.2 3.4 ± 0.9 2.9 ± 1.2 3.9 ± 1.2 6 ± 1.3 2.2 ± 0.6 6.3 ± 1.3 – – – – –
A value of 1 was assigned if the virus was detected from the undiluted sample of mice in three embryonated hen eggs and 1.5 was assigned if the virus was detected
from the undiluted sample of guinea pigs. aVirus titers are expressed as means ± SD in log10EID50/g of tissue. bNo detected.
Table 2 |The amino acids substitution among DK/357, DK/357-T, and
DK/357-L.
Amino acid substitution
Viruses NP PB2
417 96 135 688 701
DK/357 N V F S D
DK/357-T S I F S N
DK/357-L S I Y F N
Amino acids sites were located by taking A/Gs/GD/1/96 as reference.
The DK/357-L virus was replicated to the mean titers of
6.6, 3.4, 2.9, and 3.9 logEID50 in the lung, spleen, kid-
ney, and brain, respectively (Table 1). The mean virus titers
were higher than that in the lung and brain after infec-
tion with the original DK/357 virus but lower in the spleen
and brain than that after infection with the original DK/357
virus.
To investigate the morbidity and mortality of DK/357-T and
DK/357-L in guinea pigs, the previously described intranasal
inoculation procedures were performed using DK/357-T and
DK/357-L for the virus inoculum with groups of eight guinea
pigs for each. As observed in the original DK/357 virus,
neither of the viruses caused morbidity in guinea pigs. In
the organs of the three sacriﬁced animals from each group
on 3 DPI, the DK/357-T virus had replicated in the nasal
turbinates, tracheas, and lungs with mean titers of 6.8, 2.8,
and 6 log10EID50, respectively (Table 1). The virus was even
found in the brain of one guinea pig with a titer of 2.7
log10EID50. After infection with the DK/357-L virus, the virus
was also found in the nasal turbinates, tracheas, and lungs
of the sacriﬁced animals with mean titers of 6, 2.2, and
6.3 log10EID50, respectively (Table 1). Overall, the replica-
tion ability of the two viruses was higher than the original
virus isolate; however, the mean titer value in the trachea
of the guinea pigs infected with DK/357-L was lower than
that of the guinea pigs infected with the original DK/357
isolate.
TRANSMISSION ABILITY OF THE DK/357-T AND DK/357-L BETWEEN
CO-CAGED GUINEA PIGS
In order to investigate the transmission ability of DK/357-T and
DK/357-L in guinea pigs, the previously described guinea pig
inoculation and co-cage procedures were repeated using DK/357-
T andDK/357-L.At 5DPC, the virus was only detected in the nasal
turbinates of two of the guinea pigs co-caged with the guinea pigs
inoculated with the DK/357-T with a mean titer 2.1 logEID50. In
comparison, the virus was only detected in the nasal turbinates of
one guinea pig co-caged with the guinea pigs inoculated with the
DK/357-L with a mean titer 1.8 log10EID50.
DISCUSSION
From 2003 through 2 October, 2014, 668 laboratory-conﬁrmed
human cases of H5N1 AIV infection have been ofﬁcially reported
to WHO from 16 countries. Of these cases, 393 have died
(http://www.who.int/). Most patients who had conﬁrmed infec-
tions of H5N1 HPAIV died of respiratory failure complicated
by acute respiratory distress syndrome; in most instances, the
viral infection resulted from direct exposure to poultry or poul-
try products infected with H5N1 HPAIV (Beigel et al., 2005).
However, some very limited human-to-human transmission has
been detected (Ungchusak et al., 2005). The H5N1 viruses of
clade 2.3.2 increased in prevalence in poultry and wild birds
and became the dominant clade, especially in the mainland of
China and Hong Kong during 2008–2009 (Smith et al., 2009;
Li et al., 2010). We also isolated some H5N1 HPAIV viruses
of clade 2.3.2 in 2008 and 2009. This study was undertaken
to determine the pathogenicity of the virus of this period
to mice and guinea pigs and the transmissibility between
guinea pigs.
Mice have previously been used as a mammalian animal
model when evaluating the pathogenicity of the inﬂuenza virus
(Gubareva et al., 1998). In this study, mice were highly suscepti-
ble to infection with the DK/357 virus; in fact, all mice exposed
to the virus died by 7 DPI, i.e., 100% morbidity and mortality.
The virus was isolated from all harvested tissues at relatively high
virus titers. In contrast, when guinea pigs were inoculated with the
DK/357 virus, none of guinea pigs died, but the virus was able to
replicate in some tissues of the guinea pigs (Table 1). Our ﬁndings
indicated that the pathogenicity of the DK/357 virus in mice and
guinea pigs was different.
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FIGURE 2 | Lethality of the DK/357-T and DK/357-L viruses to mice. Survival curves of the mice inoculated with DK/357-T and DK/357-L viruses at a dose of
106 EID50.
Like humans and ferrets, guinea pigs can be productively
infected by human (i.e., unadapted) inﬂuenza virus isolates,
develop an upper respiratory tract infection, and transmit the
virus to other guinea pigs in both contact and non-contact sit-
uations (Lowen et al., 2006). In addition, guinea pigs have been
successfully used as models to evaluate the transmissibility of
AIVs and other inﬂuenza viruses in mammalian hosts (Lowen
et al., 2006; Bouvier et al., 2008; Lowen et al., 2009; Mubareka
et al., 2009; Steel et al., 2009; Van Hoeven et al., 2009). In this
study, the DK/357 isolate could replicate in some tissues of
the guinea pigs but did not cause morbidity. The transmis-
sion experiment results showed the virus could be transmit-
ted among guinea pigs. Interestingly, one co-caged guinea pig
showed slight clinical symptoms at 9 DPC. This guinea pig was
euthanized, and the virus was isolated from the trachea (i.e.,
designated DK/357-T) and lung (i.e., designated DK/357-T).
Sequenced results showed N417S mutation in the NP pro-
tein and V96I, D701N mutation in the PB2 protein in these
two viruses (Table 2). Previous researches have reported that
V96I in the PB2 protein and N417S in the NP protein also
existed in low pathogenic human and/or AIV, and these muta-
tions did not enhance their pathogencity to mice (Nolting, 2008;
Qi et al., 2012; Aguirre et al., 2014). The D701N mutation in
the PB2 protein is known to affect the replicative efﬁciency of
H5N1 inﬂuenza A viruses in mice and transmissibility in guinea
pigs (Li et al., 2005; Gao et al., 2009; Steel et al., 2009; Gabriel
et al., 2013; Czudai-Matwich et al., 2014). These previous reports
prompted us to evaluate the pathogenicity of these two viruses
in mice and guinea pigs and their transmissibility among guinea
pigs.
The DK/357-T and DK/357-L isolates manifested an increased
pathogenicity inmice; indeed, they causedmore severe weight loss
and demonstrated stronger replication capability than DK/357.
Although the replication capability of DK/357-T and DK/357-
L was a little higher than that of DK/357 in guinea pigs
(Table 1), they were not lethal to guinea pigs. In addition,
when guinea pigs were inoculated with DK/357-T, the virus
was found in the brain of one guinea pig. Czudai-Matwich
et al. (2014) reported that mutation D701N led to an increase
in polymerase activity and replication efﬁciency in mammalian
cells and in mouse pathogenicity, and this increase was signif-
icantly enhanced when mutation D701N was combined with
mutation S714R. Steel et al. (2009) found that when PB2 627
holds a glutamic acid residue, the D701N mutation not only
improves viral growth in mammalian cells but enhances trans-
mission of both human inﬂuenza viruses and AIVs among
guinea pigs. Multi-genes of H5N1 AIV would affect virus’s
ability to transmission among the mammals. Gao et al. (2009)
reported the 701N in the PB2 protein was a prerequisite for
A/duck/Guangxi/35/01 transmission in guinea pigs. However,
an amino acid change in the HA protein (T160A), resulting in
the loss of glycosylation at 158–160, was responsible for HA
binding to sialylated glycans and was critical for H5N1 virus
transmission in guinea pigs (Gao et al., 2009). In our study, the
D701N mutation in PB2 protein did not enhance the virus’s
transmission ability among guinea pigs which suggest other
genes may affect virus’s ability to transmission among the guinea
pigs.
In summary, our ﬁndings illustrated that the H5N1 duck-
origin inﬂuenza virus that belongs to the 2.3.2 clade demonstrated
high pathogenicity in mice. This virus only replicated in some
tissues of the guinea pigs without production of clinical signs
but could be transmitted among guinea pigs. Interestingly, the
viruses isolated from the co-caged guinea pigs had a D701N
mutation in the PB2 protein. These mutant viruses showed
higher pathogenicity in mice and higher replication capability
in guinea pigs; however, these viruses did not show enhanced
transmissibility among guinea pigs. Therefore, the continued
evaluation of the pathogenicity and transmissibility of AIVs in
mammals is critical to the understanding of the evolutionary
characteristics of AIVs and the emergence of potential pandemic
strains.
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